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Preliminary studies have been conducted on various parameters in order to assess the
possible and relative toxicities of a number of metallic salts. Upon oral administration
in lethal-dose experiments, two soluble Pt4+ salts were more toxic than the other salts
tested. Following intraperitoneal injection in lethal-dose experiments, PbC1, was less
toxic than several of the soluble or partially soluble salts of Pt'+, Pd2+, and Mn'+. An
intake of a total of approximately 250 mg of Pt4+ per rat in the drinking fluid over a
30-day interva&l did not affect the activities of aniline hydroxylase and aminopyrine
demethylase in rat liver microsomes. In rats receiving soluble Pt4+ salts in the drinking
fluid, the highest concentration of Pt was found in the kidney and an appreciable concen-
tration was found in the liver.
Introduction
Preliminary studies have been conducted
on various parameters in order to assess the
possible and relative toxicities of a number
of metallic salts. The chloride, sulfate, and
oxide salts of lead, manganese, platinum,
and palladium were studied, since it is con-
sidered that some of these salts may be in-
cluded in automotive emission products.
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mental Protectidn Agency, Research Triangle Park,
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Materials and Methods
All experimental studies were conducted
with male Sprague-Dawley rats. The ani-
mals were received at 3-3.5 weeks of age
and were maintained for 1-1.5 weeks before
use. The mean body weights were usually
100-110 g when the rats were used for the
lethal-dose experiments or started on the
diets.
In the lethal dose experiments, the salts
were administered orally (via stomach tube)
or intraperitoneally. The rats were observed
through a 14-day observation period. In the
completed experiments, the LD50 values were
calculated by the method of Litchfield and
Wilcoxon (1).
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maintained per cage. The metallic salt under
study was dissolved in the drinking fluid.
Animals consumed feed and drinking fluid
ad libitum. Analyses for metals were per-
formed on samples from three lots of feed
(Purina Laboratory Chow). The feed con-
tained (mean ± standard deviation): 56 -+-
5 mg Mn/kg feed and 0.99 + 0.07 mg Pb/kg
feed; the analyses of the three lots for
platinum were 0.09, <0.02, and <0.02 mg
Pt/kg feed. Measurements were made of the
body weights of individual rats and feed and
fluid consumption per cage of four rats at
7-day intervals during the course of each diet
experiment.
At the termination of the dietary experi-
ments, samples of liver were used for the
isolation of microsomes. Aniline hydroxylase
was measured by the method of Imai et al.
(2), modified by the addition of HgCl2 (3).
Aminopyrine demethylase was measured by
the formation of formaldehyde (Nash re-
action) (4).
The analyses of the rat tissues for plati-
num, lead, and manganese were carried out
by Yoakum, Stewart, and Sterrett (5) of
Stewart Laboratories, Inc. by an emission
spectrochemical method.
Results and Discussion
In Table 1 are presented, for various salts,
the preliminary data on the LD,O values, the
doses lethal to 50% of the rats following oral
administration or intraperitoneal injection.
Upon oral administration, the toxicities of
the salts are in the following decreasing
order (expressed on a molar basis): PtCl,
Pt(SO4)2 . 4HoO > PdCl2 * 2H.O, RuCl3 >
MnCl2 * 4H2O, PdSO4, PbCl2, PtC12 > PtO2 >
MnO2, PdO. Thus, upon oral administration,
the two soluble Pt4+ salts are the most toxic
of the compounds studied. As one might an-
ticipate, the highly insoluble salts are least
toxic and include PtCl2 (Pt2+) and oxides
of platinum, manganese, and palladium. The
relative order of toxicities may be modified
somewhat by the period of observation. Al-
Table 1. Acute toxicities of various metallic salts.
LD5(,, mmole/kg
Compound
Oral Intraperitoneal
MnCl2*4H20 7.5a 0.70a
(7.0-8.1) (0.61-0.80)
MnO2 >>40
PbCl2 >7 >4.5
PdC12*2H20 2.7a 0.4 -0.6
(2.2- 3.4)
PdO >40
PdSO4 >7 >0.6
PtCl2 >5 >>0 9
PtCl4 <1.9 <<1.2
PtO2 >15 -
Pt(SO4)2.4H20 2.2& 0.68a
(1.6-3.1) (0.60-0.76)
RuCls 2.8-3.5
a Evaluated by the method of Litchfield and Wilcoxon
(1); the ranges of the 95% confidence limits are given
in parentheses.
though the soluble Pt4+ salts kill early,
usually within the first 1-2 days following
oral administration, the palladium salts and
PbCl2 often kill 4-10 days after adminis-
tration.
The LD50 doses following intraperitoneal
injection are also presented in Table 1. The
relative order of the LD50 values are, on a
molar basis: PdCl2 * 2H20> Pt(SO4)2 * 4H2Q,
MnCl2 . 4H20, PdSO4, PtCl4 > PbCl2, PtC12.
The most toxic salt was PdCl2 * 2H20. PbC12
was less toxic following intraperitoneal in-
jection than the soluble Pt4+ salts and
MnCl2 * 4H,O.
In the process of preparing rats for sub-
sequent biochemical experiments, measure-
ments were made at 7-day intervals of the
weight gain by individual animals and the
feed and drinking fluid consumption per
cage of four rats. Usually each control rat
gained 50-60 g per week during each of the
first 4 weeks on the diets. The weight gain
by rats which consumed 8.3mM MnCl2-
4H20 (one week) or 3.7mM PbCl2 (four
weeks) did not differ from the weight gain
by control rats (Fig. 1A). Furthermore,
when the drinking fluid was a saturated solu-
tion of PtCl2 or of PdCl2 * 2H20, no statis-
tically different weight changes were ob-
served, although the PdCl2 * 2H20 appeared
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to cause some decrease (Fig. 1B). The satu-
rated solution of PtCI2 contained only a trace
of Pt (14 jug Pt/l.); the saturated solution
of PdCl2 4H20 has not been analyzed yet
for Pd.
A soluble salt of Pt4+, when added to the
drinking fluid as 0.54mM PtCl,, did not
affect the weight gains for the four weekly
or the total interval (Fig. 1C). When the
Pt4+ concentration was increased 3-fold with
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WEEK OF DIET
1-4
240
220
200
240
220
200
C
FIGURE 1. Weight gain (g/week/rat or g/4 weeks/
rat) receiving various salts in the drinking fluid.
(A) MnCl2 4H2O, 8.3mM or 1640 mg of salt/I.;
PbCl2, 3.7mM or 1022 mg of salt/I.; (B) PtCl2,
saturated solution; PdCl2 * 2H20, saturated solu-
tion of the first aqueous extraction of the salt;
(C) PtCl4, 0.54mM or 183 mg of salt/I.; PtCl,
1.63mM or 550 mg of salt/l.; Pt(S04)2 * 4H20,
1.63mM or 750 mg of salt/l. Each point is the
mean of a minimum of 8 male rats (usually 12-16
rats): (0) control; (5) metal-treated animals;
vertical bars are standard deviations.
either 1.63mM PtCl4 or Pt(SO4)2 4H20, the
weight gains of the metal-treated rats was
significantly less than the gains of the con-
trol rats during the first week on the diet.
However, 1.63mM PtCl4 did not decrease the
weight gains during the second, third or
fourth weeks. The decreases of 20%o in
weight gain during the first week were par-
allel to the decreases in feed consumption
and fluid consumption which were also
decreased by 20%o.
The organ weights, expressed as the per-
centage of the body weight, of control and
metal-treated rats are given in Table 2. PbCl2
(3.67mM) did notsignificantly alterthe organ
weights through a 30-31 day diet; the total
lead intake was approximately 750 mg of lead
per rat for the entire interval. When essen-
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97Table 2. Effect of various salts in the drinking fluid on tissue weights. a
Drinking fluid Dura- Body Organ weights, % of body weight b,o
tion, No. of weight,
Salt Concn, days rats g Liver Kidney Spleen Heart Testes
mM
Controls 29-31 8 309 3.41 0.92 0.28 0.32 1.04
PbCls 3.67 29-31 8 309 3.47 0.98 0.30 0.33 1.03
Controls 90-91 4 508 2.64 0.68 0.19 0.25 0.75
PbCl, 3.60 90-91 4 456 2.96 0.80 0.24 0.27 0.76
(90) (112) (117) (129)t
Controls 8 8 136 3.70 1.07 0.51 0.36 1.13
PdCI2*2H20 Satd. 8 8 132 3.76 1.06 0.58 0.37 1.21
(114)
Controls 29-30 8 297 3.52 0.86 0.43 0.31 1.06
PtCl 0.54 29-30 8 285 3.52 0.91 0.41 0.33 1.07
Controls 8 12 152 3.72 1.07 0.58 0.38 1.08
PtCl, 1.63 8 12 145 3.72 1.13 0.57 0.39 1.11
Controls 29 12 306 3.27 0.85 0.27 0.31 1.03
PtCl4 1.63 29 12 296 3,.29 0.92 0.28 0.32 1.13
(108)* (110)
Controls 8-9 8 173 3.90 1.01 0.56 0.39 1.11
Pt(SO4),.4H20 1.63 8-9 8 149 3.69 1.05 0.54 0.37 1.21
(86) (109)
* Since livers were used for isolation of microsomes,
rats were fasted overnight (12-15.5 hr before collection
of tissues; drinking fluid provided during fasting.
b Where mean of tissues from metal-treated rats is
tially the same diet was continued for
approximately 90 days, the kidneys were
enlarged. These data are consistent with
prior reports (6) and with our preliminary
data which showed kidney enlargement in
rats which received one-half this concentra-
tion over a 90-day interval. When PdCl2,
2H20 was extracted with water to dissolve
the readily soluble material and that solution
used as the drinking fluid, no significant
changes were observed in the organ weights
over an 8-day interval.
The dietary administration of PtCl4 did
not affect any of the five organ weights when
the PtCl, was included in the drinking fluid
for approximately 30 days at 0.5mM or for
8 days at 1.6mM. Likewise, if 1.6mM
Pt(SO4)2 . 4H20 was given as drinking fluid
for 8-9 days, there were no significant
changes in organ weights. The total intake
of platinum per rat was approximately 60
mg for each of these three Pt4+ diets. In
contrast, if 1.6mM PtCl4 is administered for
approximately 30 days (total intake of ap-
proximately 250 mg of Pt per rat), the
outside of the range of 92.0-108.0% of the mean of con-
trol rats, the percentage is given in parentheses.
e Statistical analysis (Student's t-test): *, P <0.05
t, 0.05 <P <0.10; no markingis indicated where P>0.10.
kidney weight was increased 6-10lo in each
of the three experiments.
At the termination of the dietary experi-
ments, samples of liver were used for the
isolation of microsomes. Measurements were
made of the weight of microsomal protein
isolated per gram of liver and the activities
of two microsomal enzymes: aniline hydroxy-
lase and aminopyrine demethylase.
None of the dietary treatments consis-
tently affected the level of microsomal pro-
tein isolated per gram of liver (Table 3).
The hepatic activities of aniline hydroxylase
or aminopyrine demethylase are not sig-
nificantly depressed when rats were main-
tained for only 30 days on 3.7mM PbCl2
in the drinking water. The use of a saturated
aqueous solution of PdCl2 * 2H20 as the
drinking fluid appears to decrease the activi-
ties of both aniline hydroxylase and amino-
pyrine demethylase. Under various concen-
tration and duration schedules, the addition
of the soluble chloride (or sulfate) salt of
Pt4+ to the drinking fluid did not alter the
activity of either microsomal enzyme.
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microsomal activities of rat liver.
Drinking fluid (Treated/control) X 100&
Dura-
ation, Micro- Ani- Amino-
Salt Conc, days somal line pyrine
mM pro- hydrox- demeth-
teinb ylase¢ ylased
PbCl, 3.67 31 107 79t 87
30 101 99 95
PbCl2 3.60 91 75 71 86
PdCl2*2H20 Satd. 8 96 67* 66**
8 113t 77t 90*
PtCl4 0.54 29 98 106 109
30 98 94 103
PtClh 1.63 8 105 107 104
8 99 121 125
8 100 79* 88
PtCl4 1.63 29 95 108 101
29 94 92 100
30 107 93 99
aStatistical analysis (t-test: **, P<0.01; *, P<0.05;
tO.05 <P<0.10; no marking if P>0.10. Each value is a
comparison of the mean of four control values and values
from four metal-treated rats.
b In control rats, approximately 43 mg of microsomal
protein was obtained per gram of liver.
e Aniline hydroxylase: control values were approxi-
mately 18 m,umole of p-aminophenol produced/mg
protein/20 min incubation.
d Aminopyrine demethylase: control values were ap-
proximately 70 m,umole of formaldehyde produced/mg
protein/10 min incubation.
Analyses for lead, manganese, and plati-
num were conducted by Yoakum, Stewart,
and Sterrett (5). In a series of rats treated
for 90-91 days, the control rats ingested
approximately 0.15 g of manganese (from
the solid feed). The tissue concentration of
Mn was 1.4 and 1.0 ug Mn/g wet tissue in
the liver and kidney, respectively. In Mn-
treated rats, which received 8.3mM MnCl2,
4H0O as the drinking fluid and ingested
approximately 2.3 g of Mn per rat during
the 90-91 day interval, the concentration
of Mn was somewhat increased, namely 2.8
and 1.6 ,ug Mn/g of wet tissue in the liver
and kidney, respectively. The Mn concen-
tration in spleen, heart, testes and blood
was not increased in the tissues of Mn-
treated rats.
A second group of rats received 3.6mM
PbCl2 in the drinking water for 90-91 days
and ingested approximately 3 g of lead per
rat during the interval; control rats ingested
< 0.01 g of Pb in the solid feed during the
same interval. Kidney showed a marked
accumulation of Pb (to 11.1 Mug Pb/g of wet
tissue) in the lead-treated rats; in the same
rats the concentration in liver was 1.2 Mug
Pb/g of wet tissue. The corresponding levels
in the control rats were approximately 0.3
,Xg Pb/g of wet tissue in both kidney and
liver. The other tissues (spleen, heart, testes,
and blood) did not exhibit appreciably higher
levels of Pb in the Pb-treated rats.
Soluble Pt4+ salts were included in the
drinking fluid of rats for 8-9 days. The
approximate total Pt intake (mg Pt per rat)
and data on the tissue concentration of Pt in
various tissues are presented in Table 4.
Although the Pt concentrations in tissues of
untreated control rats often attain levels
measurable by the technique used by Stewart
Laboratories, Inc., the levels are low and are
generally less than 0.1 ptg Pt/g of wet tissue.
For the higher levels of Pt4+ intake in the
Pt-treated rats, the highest tissue concen-
trations of Pt occurred in the kidney and
ranged from 4.5 to 5 MLg Pt/g of wet tissue.
High levels, ranging from 0.7 to 2.5 Mlg Pt/g,
also occurred in the liver. In contrast, brain
showed only a very low level of Pt which may
reflect a contribution from the blood. Sep-
arate experiments were conducted on the
tissue concentrations of Pt in rats which
received a saturated solution of PtCl2 as the
drinking fluid for 30-31 days. In the PtCl2-
treated rats, the mean Pt concentration for
liver, kidney, and spleen was < 0.08 ,ug Pt/g
of wet tissue.
In Table 5 are presented the Pt concen-
trations of tissues removed from rats which
had survived for the 14-day observation
period in lethal-dose experiments. The doses
of Pt(SO4)2 . 4H2O administered by both the
oral and intraperitoneal routes were approxi-
mately 90% of the LD50 values by the re-
spective routes. During the two-week obser-
vation period, the rats gained weight at a
rate from one-third to three-fourths the rate
of the control rats. In the orally treated rats,
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Control Pt(SO4)2.4H20 PtCl4
Pt salt concn, mg Pt/I. 106 319 319
Duration of diet, days 8 9 8
Total Pt intake, mg Pt/rat <0.01 26 80 60
Tissue concentration of Pt, pg Pt/g
wet tissue
Liver 0.07 0.85 2.2
<0.02-0.02 (0.04-0.09) (0.73-0.97) (2.0-2.5)
Kidney 4.6
<0.23-0.45 0.26+0.05 (4.5-4.7) 4.840.5
Spleen 0.02 0.13 0.24
<0.08i0.08 (0.01-0.02)
Heart <0.02±0.01 0.02 0.25
Testes <0.014 -0.010 0.04+40.05
Brain - 0.015±+00.002
Blood 0.05 0.22 0.23
0.10 ±0.13 (0.09-0.36) (0.19-0.27)
a Values for control rats are those from diet experiments after approximately 8 or 30 days; 5-7 values
for blood, spleen, and heart, 13-16 values for liver, kidney, and testes; standard deviation (±) is given for
means with at least four values; ranges are indicated in parentheses for means of two values.
Table 5. Pt concentration in rat tissues following the administration of single high doses of Pt (SO4)2.4H20.
Controls Pt(SO4)2*4H. O
(oral)
Oral Intraperitoneal
Dose of Pt, mg Pt/kg 382 113
Tissue Concentration of Pt, pg Pt/g wet
weight of tissue
Liver <0.01 2.3 34
(0.004-0.006) (1.2-3.5) (30-38)
Kidney <0.008 16 37
(0.004-0.004) (13-19) (28-46)
Spleen <0.013 3.3 16
(0.007-0.011) (2.3-4.2) (12-20)
Heart 0.02 0.8 3.0
Testes 0.011 0.5 1.2
(0.009-0.013) (0.4-0.6) (0.9-1.5)
Brain 0.01 0.10 0.6
(0.07-0.14) (0.07-1.1)
Blood <0.008 3.3 1.0
a Range of four values for control liver, kidney, and spleen, and range of 2-3 values of all other tissues
are given in parentheses. Control values are the mean values of Pt concentration in two rats which received
orally NaCl.
the highest concentration of Pt occurred in
the kidney (approximately 16 ,Ag Pt/g), and
appreciable levels of Pt also occurred in liver
and spleen (range, 1-4 ug Pt/g of wet tissue).
In the intraperitoneally dosed rats, the kid-
ney, liver, and spleen showed very high levels
of Pt in the range of 10-40 ug Pt/g of wet
tissue.
In a comparable lethal dose experiment,
rats were treated orally with a dose of
MnCl, * 4H20 equivalent to 100%o of the oral
LD50 value, and the tissues were analyzed
in surviving rats at the end of the 14-day
observation period. In contrast to the finding
with the Pt salt, the oral administration of
a single, large but nonlethal dose of MnCl
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the oral administration of a single large dose
of MnCI2.4H20.
Controls MnCI2 4H20
Dose of Mn, mg Mn/kg 416
Tissue concentration of
Mn, jsg Mn/g wet
weight of tissues
Liver 1.60±i0.87 1.9
(1.3-2.5)
Kidney 0.75±0.50 1.3
(1.0-1.5)
Spleen 1.46±1.99 1.3
(1.1-1.5)
Heart 0.55±0.35 0.7
Testes 0.44±0.35 0.5
(0.4-0.5)
Brain 0.3 0.03
Blood 0.86±0.44 0.4
(0.2-0.6)
* Control values are from rats treated orally with
NaCl, and rats on diet experiments for approximately
8 or 30 days. Means + standard deviations are given
for 6-7 samples of spleen, heart and blood and for 13-18
samples of liver, kidney and testes from control rats;
ranges are given in parentheses where two values are
available from Mn-treated rats.
4H20 to rats did not result in the retention
after 14 days of excess concentrations of Mn
in any of the tissues analyzed (Table 6).
Due to low levels of absorption and/or a high
capacity for excretion of the Mn, the tissue
Mn levels of the experimental rats were ap-
proximately equal to the levels found in
control rats.
These studies show that in rats treated
with soluble Pt4+ salts, appreciable levels of
the metal can be found in the kidney, liver,
and spleen. Further studies will be necessary
to determine the effects of the Pt and other
metals on various biochemical reactions.
Acknowledgments
The work upon which this publication is
based was performed persuant to Contract
No. 68-02-1205 with the Environmental
Protection Agency. DJH was supported by
Research Career Development Award 5-
K04-GM70114 from the National Institutes
of Health.
We gratefully acknowledge the technical
assistance of Mary C. Parker and Elaine Y.
Shafer, and the participation of Herman S.
Lilja.
Appreciation is expressed to A. M. Yoakum
and P. L. Stewart of Stewart Laboratories
Inc. and to Dr. Joseph Bumgarner of the
Environmental Protection Agency for the
analyses of the tissue samples for various
metals.
REFERENCES
1. Litchfield, J. T., and Wilcoxon, F. A simplified
method of evaluating dose-effect experiments.
J. Pharmacol. Exp. Therap. 96: 99 (1949).
2. Imai, Y., Ito, A., and Sato, R. Evidence for bio-
chemically different types of vesicles in the
hepatic microsomal fraction. J. Biochem. (Tokyo)
60: 417 (1966).
3. Chhabra, R. S., Gram, T. E., and Fouts, J. R. A
comparative study of two procedures used in the
determination of hepatic microsomal aniline hy-
droxylation. Toxicol. Appl. Pharmacol. 22: 50
(1972).
4. Schenkman, J. B., Remmer, H., and Estabrook,
R. W. Spectral studies of drug interaction with
hepatic microsomal cytochrome. Mol. Pharmacol.
3: 113 (1967).
5. Yoakum, A. M., Stewart, P. L., and Sterrett, J. E.
Method development and subsequent survey anal-
ysis of biological tissues for platinum, lead and
manganese content. Environ. Health Perspect.
No. 10: 85 (1975).
6. Hirsch, G. H. Effect of chronic lead treatment on
renal function. Toxicol. Appl. Pharmacol. 25: 84
(1973).
April 1975 101